Denali Therapeutics Inc（DNLI）價格預測DNLIDenali Therapeutics Inc

Alphio's DNLI stock price prediction model matches the current Denali Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.63 (-0.18%). The 1-week path is $18.56 (-0.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Denali Therapeutics Inc (DNLI) is a good buy right now due to its recent revenue growth of $3.6 million in Q2 2026, which exceeded expectations by $1.41 million, and a strong cash position of approximately $940 million that supports future R&D. The stock's current price of $18.41 is well below analyst price targets of $30 to $36, suggesting substantial upside potential. However, the company has reported a net income loss of $127.55 million in Q2 2026, which poses a risk to profitability moving forward.

Denali Therapeutics Inc (DNLI) last closed at $18.6599998, gaining +1.36%. These facts feed the 1-day and 1-week DNLI price prediction above.